Menopause

New research indicates that women may be able to reduce menopausal symptoms by increasing their intake of fruits and vegetables (FV).

The overview underscores the importance of considering a woman’s age and time since menopause.

The North American Menopause Society (NAMS) will hold its 31st Annual Meeting at the Gaylord Rockies Hotel in Denver from Sept. 30 to Oct. 3, 2020.

Accelerated biological aging was seen in women who had severe menopausal vasomotor symptoms (VMS) on enrollment in the Women’s Health Initiative Observational Study (WHI-OS), or late-occurring VMS (at enrollment but not at/during their reported menopause transition, according to a study in The Journal of Clinical Endocrinology & Metabolism.

For postmenopausal women with at least one vulvovaginal atrophy (VVA) symptom, the presence of physician-confirmed VVA is linked to significant impaired sexual function, according to a study from the European Vulvovaginal Epidemiological Survey (EVES).

Social inequalities profoundly impact South Korean postmenopausal women who have metabolic syndrome and osteoporosis, according to a cross-sectional study in the journal Menopause.

The timing of postmenopausal hormone therapy (HT) significantly impacts coronary risk and overall benefit-to-risk profile, according to an overview of Women’s Health Initiative (WHI) results in the journal Menopause.

New research indicates having at least one symptom of vulvovaginal atrophy is linked to significant impaired sexual function for postmenopausal women.

Accelerated biological aging was seen in women who had severe menopausal vasomotor symptoms but not during their reported menopause transition, according to new research.

A study in Menopause found that a significant proportion of premenopausal and perimenopausal women experienced hot flashes after receiving breast cancer treatment.

New research indicates that women may be able to reduce menopausal symptoms by increasing their intake of fruits and vegetables (FV).

Hormonal therapy is not without controversy but it is still one of the most effective treatments for patients with symptoms.

New research has found that the role of hormone therapy (HT) in menopausal patients with breast cancer and gynecologic malignancies is a mixed bag.

Women who reach menopause before age 40 may have an increased risk for subsequent cardiovascular disease, according to research from JAMA.

Menopausal women with frequent night sweats have more sleep, but that may not be a plus for brain function, according to a study presented at The North American Menopause Society (NAMS) Annual Meeting in Chicago in September.

Research from the American Journal of Obstetrics & Gynecology indicates that menopausal white women gain significantly more abdominal fat than black women, potentially increasing their risk of type 2 diabetes and CVD.

A new study, which found that women with premature and early menopause were at increased risk of having a non-fatal cardiovascular disease event before age 60, has consequential public health and clinical implications.

Although nearly half of postmenopausal women reported having vulvovaginal symptoms (VVS), only a minority discussed their symptoms during a well-woman visit with a primary care provider or gynecologist, according to recent survey analysis.

A recent study describes the development of a web-based calculator that predicts the likelihood of experiencing multiple and competing morbidity outcomes over 5, 10, and 15 years.

A recent study evaluated the impact of menopause on multiple sclerosis (MS), including disease activity and disability progression.

New research explored whether midlife women with type 2 diabetes mellitus (T2DM) are at higher risk of sleep-related symptoms.

New research examines whether women who experience a heart attack, stroke or other type of cardiovascular event before age 35 have a higher risk of early menopause.

A new study aims to clarify the quantitative association between age at menopause and T2DM.

GSM can be clinically detected in up to 90% of postmenopausal women undergoing evaluation but only one-third report vulvovaginal symptoms when surveyed.